EMERGING TECHNOLOGY AND MODERNIZING THE ARMY
the services to verify that all branches had their CBRN detection and identification needs met.
Upon completion of the technology’s experimentation and demonstration, a validated Capability Development Docu- ment was endorsed by the JRO Counsel in 2014, indicating that the capability met the requirements set forth by DOD to protect and defend warfighters downrange.
A defining aspect of the JBTDS project has been the collaboration among various U.S. government agencies. JPEO-CBRND played a pivotal role in bringing together experts from different domains to foster the development of this much-needed detection capability. For example, the U.S. Army Combat Capabilities Develop- ment Command’s (DEVCOM) Chemical Biological Center (CBC) provided crucial technological advancements using its
cutting-edge research capabilities and ingenuity to design a biological warfare agent trigger and detector that could be integrated with the JBTDS.
joint capabilities integration and develop- ment system process, which defines DOD acquisition requirements and evaluation criteria, even as other stakeholders worked to qualify the system.
The JBTDS’ journey is far from over.
DEVCOM CBC contributed its vast biological detection experience, while the Defense Treat Reduction Agency’s Joint Science and Technology Office, which, along with the JPEO-CBRND and JRO is part of the larger Chemical and Biological Defense Program (CBDP) and a science and technology development partner of the JPEO-CBRND, lent expertise in emerging and novel threats. Meanwhile, the CBDP’s JRO assisted in navigating the
A GAME CHANGER The JBTDS offers several advantages that make it a game changer in the field of biological threat detection. First, the system provides real-time detection and identification of biological agents, allow- ing for swift and informed responses to potential threats. Te system is also versa- tile, so it can be used on a wide range of operational environments, from military
FIRST OF ITS KIND
U.S. Special Operations Command Soldiers conducted simulation testing on the Biomeme 3/9 Integrated Sample Prep JBTDS Identifier at Joint Expeditionary Base Little Creek-Fort Story, Virginia in October 2022. This device is the first of its kind to provide polymerase chain reaction identification, where warfighters can identify a pathogen at the point of collection rather than transporting samples to laboratories.
https://asc.ar my.mil
27
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120
